Clinical Trials

Our Members Actively Seek Patients for Clinical Trials

The UNMC Lymphoma Team has clinical trials open for newly diagnosed and relapsed patients with all different subtypes of Hodgkin and non-Hodgkin lymphoma.  Therapies we evaluate include new chemotherapies, pathway directed agents, immunotherapy, and high dose therapy with cellular therapy such as blood and marrow transplantation or CAR-T cells.  Included in the clinical trials are translational correlates on blood and lymph node biopsies to improve the translational research goals.


Dr. Lunning (right)

Matthew Lunning, D.O., member of our Center, is seeking patients with diffuse large B-cell lymphoma to participate in his Phase 2 Study.  If you are interested, access the trial information at:  TGR-1202 and Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.  For direction to other leukemia or lymphoma trials at UNMC contact the Center for Clinical & Translational Research at 402-559-6941.

Members are actively recruiting patients for clinical trials.  Visit the links to the left of this page to learn more about clinical trials and those involving our members at UNMC.